BRISTOL-MYERS SQUIBB COMPANY for BRISTOL-MYERS SQUIBB COMPANY
What was lobbied
8 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
S.2209, Research Credit Improvement Act. Lobbied in favor of permanent research and development tax credits.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN RYAN | — |
Trade (domestic/foreign) TRD
Sprycel Reimbursement in Korea. Lobbied to get Korean Government to adhere to its reimbursement procedures.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID E WARR | — |
Health Issues HCR
H.R. 5629, Pathway for Biosimilars Act. Lobbied Members of Congress in support of an FDA pathway for biosimilar products, patient safety, and data exclusivity. H.R. 1424, The Paul Wellstone Mental Health and Addiction Equity Act. Lobbied Members of Congress in support of mental health parity and against increased Medicaid rebates. S. 2731/ H.R. 5501, Tom Lantos and Henry J. Hyde United States Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008. Lobbied Members of Congress in support of reauthorization of the Presidents Emergency Program for AIDS Relief. S. 558, Mental Health Parity Act. Lobbied Members of Congress in support of mental health parity and against increased Medicaid rebates. H.R. 1038/S. 623, Access to Life-Saving Medicine Act. Lobbied to protect incentives to innovate new biologic drugs and to ensure appropriate safeguards for follow-ons. H.R. 1956, Patient Protection and Innovative Biologic Medicines Act. Lobbied to protect incentives to innovate new biologic drugs and to ensure appropriate safeguards for follow-ons. H.R. 5629, Pathway for Biosimilars Act. Lobbied to protect incentives to innovate new biologic drugs and to ensure appropriate safeguards for follow-ons. S. 1505, Affordable Biologics for Consumers Act. Lobbied to protect incentives to innovate new biologic drugs and to ensure appropriate safeguards for follow-ons. H.R. 3610, Food and Drug Import Safety Act of 2007. Lobbied to ensure safety and access to prescription drugs. S. 999, The STOP Stroke Act. Lobbied for passage of bill. Labor, HHS Appropriations bill(No Bill Number Yet). Lobbied to ensure patient access to HIV drugs through the ADAP program.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL CAROZZA | — |
| LANE PENRY | — |
| CHRISTOPHER PERNIE | — |
| RICHARD THOMPSON | — |
Medicare/Medicaid MMM
S. 2320, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2007.Lobbied for passage of bill. Medicare Part D Oversight (No Bill Number Yet). Lobbied Members of Congress to educate on the benefits of private negotiation in Medicare Part D.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL CAROZZA | — |
| LANE PENRY | — |
| CHRISTOPHER PERNIE | — |
Consumer Issues/Safety/Products CSP
Infant formula can liners (No bill).Lobbied to inform Members of Congress on the safety of materials used to line cans of infant formula.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL CAROZZA | — |
Clean Air and Water (quality) CAW
Pharmaceuticals in the environment. Lobbied to educate Members of Congress on the issue of pharmaceuticals in the environment.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL CAROZZA | — |
| LANE PENRY | — |
| CHRISTOPHER PERNIE | — |
Agriculture AGR
S.B. 2302 and HR 2419, Food and Energy Security Act of 2007 Farm Nutrition and Bioenergy Act of 2007. Lobbied against the proposed non deductibility increase on companies involved with settlement agreements with government agencies.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN RYAN | — |
Copyright/Patent/Trademark CPT
H.R. 1908 and S. 1145, Patent Reform Act of 2007. Lobbied Members of Congress to improve provisions related to inequitable conduct and damages.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL CAROZZA | — |
| CHRISTOPHER PERNIE | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.